|
TBC1D14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.96560040150496E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.89029999933632E-09 |
| Normal-vs-Stage2 |
2.52430000013959E-07 |
| Normal-vs-Stage3 |
1.15430000002803E-07 |
| Normal-vs-Stage4 |
8.34920000000183E-05 |
| Stage1-vs-Stage2 |
9.327000E-01 |
| Stage1-vs-Stage3 |
8.222600E-01 |
| Stage1-vs-Stage4 |
3.811200E-01 |
| Stage2-vs-Stage3 |
7.818600E-01 |
| Stage2-vs-Stage4 |
5.165000E-01 |
| Stage3-vs-Stage4 |
3.165000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.78129999826172E-08 |
| Normal-vs-AfricanAmerican |
1.1776135622199E-12 |
| Normal-vs-Asian |
2.47169999999519E-05 |
| Caucasian-vs-AfricanAmerican |
4.426000E-01 |
| Caucasian-vs-Asian |
2.246000E-01 |
| AfricanAmerican-vs-Asian |
3.579000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.90670000291371E-08 |
| Normal-vs-Female |
2.51865195366463E-12 |
| Male-vs-Female |
6.921400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.882000E-02 |
| Normal-vs-Extreme_Weight |
3.826100E-04 |
| Normal-vs-Obese |
2.77210032706421E-10 |
| Normal-vs-Extreme_Obese |
3.55600000000456E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.533000E-01 |
| Normal_Weight-vs-Obese |
4.253000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.406600E-01 |
| Extreme_Weight-vs-Obese |
8.850200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.584400E-01 |
| Obese-vs-Extreme_Obese |
8.129000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.00219999971318E-07 |
| Normal-vs-Age(41-60Yrs) |
2.27595720048157E-14 |
| Normal-vs-Age(61-80Yrs) |
4.44330000000104E-05 |
| Normal-vs-Age(81-100Yrs) |
5.16439999653784E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.878600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.715600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.397200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.475400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.653000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.200000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.955830E-03 |
| Normal-VS-KIRP CIMP |
1.91529999638007E-08 |
| Normal-VS-Unclassified PRCC |
1.34140000218608E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.064400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.053640E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.912300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.312500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.050600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.617800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-16 |
| Normal-vs-N1 |
4.97050000047849E-07 |
| Normal-vs-N2 |
2.640500E-03 |
| N0-vs-N1 |
2.429600E-01 |
| N0-vs-N2 |
5.068000E-01 |
| N1-vs-N2 |
9.220400E-01 |
|
|
